Product Reports Resources Pricing Login Book a demo

AcuFocus

Biotech & Life Sciences · Irvine, United States · Founded 2001

AcuFocus, Inc. is a pioneering company in the ophthalmology sector, specializing in advanced intraocular lenses (IOLs) designed to improve vision for patients with cataracts and complex corneal conditions. The company's flagship product, the IC-8 IOL, is a groundbreaking lens that offers extended depth of focus and enhanced adaptability through its unique small aperture design. This innovative lens received the CE mark in 2015 and is currently available in select markets across Europe and Asia. AcuFocus primarily serves patients who are undergoing cataract surgery, a common procedure to remove the cloudy lens of the eye and replace it with an artificial one. The company also targets individuals with complex corneal issues, providing them with advanced solutions to improve their vision quality. The market for cataract surgery is substantial and growing, with projections indicating that the number of people affected by cataracts will continue to rise significantly in the coming decades. The business model of AcuFocus revolves around the development, manufacturing, and distribution of its specialized IOLs. The company generates revenue by selling these lenses to ophthalmologists and eye clinics that perform cataract surgeries. By offering a product that addresses both cataracts and corneal complexities, AcuFocus differentiates itself in the competitive ophthalmology market. AcuFocus makes money through direct sales of its IC-8 IOLs to medical professionals and healthcare facilities. The company also invests in ongoing research and development to continually enhance its product offerings and maintain a competitive edge in the market. Additionally, AcuFocus engages in educational initiatives to inform both healthcare providers and patients about the benefits of its innovative lens technology. Keywords: intraocular lenses, cataract surgery, corneal conditions, ophthalmology, IC-8 IOL, small aperture design, vision improvement, medical devices, healthcare, eye health.

Investors

7 investors on AcuFocus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
HealthCare Royalty
Medtronic
Series B+ 5 investors entered at this stage
Accuitive Medical Ventures
Three Arch Partners
Versant Ventures
SV Health Investors
KKR

Global footprint

Where AcuFocus has talent and traffic

Workforce by country
🇺🇸 United States · Irvine HQ
Book a demo for the full country breakdown

Talent graph

The shape of AcuFocus's talent

Dealroom maps AcuFocus's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

7 team members profilednamed & role-tagged by Dealroom
25 employeestotal headcount
5 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock AcuFocus's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about AcuFocus

An AI-synthesized read of the highest-engagement posts about AcuFocus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AcuFocus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.